Literature DB >> 7337987

Labelling and absenteeism: the Massachusetts Mutual experience.

M H Alderman, M E Charlson, L A Melcher.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7337987

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN： 0147-958X            Impact factor:   0.825


× No keyword cloud information.
  11 in total

1.  Assessment of quality of life in the treatment of hypertension.

Authors:  J S Callender
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

2.  Health insurance, or particularly its lack, and healthcare consequences among hypertensive Americans.

Authors:  Michael H Alderman
Journal:  Am J Hypertens       Date:  2014-10-01       Impact factor: 2.689

3.  Hypertension and sickness absence: the role of perceived symptoms.

Authors:  S Melamed; P Froom; M S Green
Journal:  J Behav Med       Date:  1997-10

4.  Race differences in the physical and psychological impact of hypertension labeling.

Authors:  Tanya M Spruill; Linda M Gerber; Joseph E Schwartz; Thomas G Pickering; Gbenga Ogedegbe
Journal:  Am J Hypertens       Date:  2012-01-19       Impact factor: 2.689

5.  Are there consequences of labeling patients with prehypertension? An experimental study of effects on blood pressure and quality of life.

Authors:  Tanya M Spruill; Seth D Feltheimer; Manjunath Harlapur; Joseph E Schwartz; Gbenga Ogedegbe; Youngjun Park; William Gerin
Journal:  J Psychosom Res       Date:  2013-02-15       Impact factor: 3.006

6.  Hypertensive labeling: does it have therapeutic implications.

Authors:  W H Birkenhäger
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

7.  Health-related quality of life in cardiac patients with dyslipidemia and hypertension.

Authors:  Lyne Lalonde; Annette O'Connor; Lawrence Joseph; Steven A Grover
Journal:  Qual Life Res       Date:  2004-05       Impact factor: 4.147

Review 8.  [Socioeconomic and quality of life repercussions of arterial hypertension].

Authors:  B Selke; P Marquis; T Lebrun
Journal:  Drugs       Date:  1998       Impact factor: 9.546

9.  Now we are sick: labeling and hypertension.

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-01       Impact factor: 3.738

Review 10.  Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature.

Authors:  Stacey L Sheridan; Eric Crespo
Journal:  BMC Health Serv Res       Date:  2008-03-20       Impact factor: 2.655
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.